You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FLT3-ITD positivity

Showing 1 - 25 of 488
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    May 17, 2022

    Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

    Not yet recruiting
    • Leukemia, Acute Myeloid (AML)
    • (no location specified)
    Oct 16, 2022

    Co-existing Mutations on Sorafenib Maintenance Therapy After

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    May 30, 2022

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

    Suspended
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 11, 2022

    Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)

    Terminated
    Has Results
    • Leukemia, Myeloid, Acute
    • Denver, Colorado
    • +4 more
    May 10, 2022

    Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
    • Cincinnati, Ohio
    • +18 more
    Jan 20, 2023

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Los Angeles, California
    • +7 more
    Mar 14, 2022

    Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Ponatinib 30 MG
    • Angers, France
    • +13 more
    Aug 4, 2021

    AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

    Unknown status
    • AML
    • FLT3-ITD Mutation
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Dec 9, 2020

    Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Loma Linda, California
    • +36 more
    Feb 1, 2023

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Bari, Italy
    • +19 more
    Mar 1, 2022

    AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

    Recruiting
    • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
    • MRD-triggered arm
    • Prophylactic Arm
    • Heidelberg, BW, Germany
      University Hospital Heidelberg Med5
    Jan 4, 2021

    Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • La Jolla, California
    • +18 more
    Mar 12, 2021

    Acute Myeloid Leukemia Trial in Germany (midostaurin (PKC412))

    Completed
    • Acute Myeloid Leukemia
    • midostaurin (PKC412)
    • Chemnitz, Germany
    • +9 more
    Aug 5, 2020

    AML, FLT3-ITD Mutation Trial in Hong Kong (Sorafenib, Omacetaxine Mepesuccinate Injection)

    Completed
    • AML
    • FLT3-ITD Mutation
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Mar 26, 2020

    FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)

    Available
    • FLT3-ITD Mutation
    • +3 more
    • Crenolanib besylate
    • Genova, Italy
      Ospedale Policlinico San Martino
    May 21, 2020

    FLT3-ITD Mutation, AML Trial in Hong Kong (Sorafenib 200mg)

    Completed
    • FLT3-ITD Mutation
    • AML
    • Sorafenib 200mg
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Mar 26, 2020

    Sorafenib to Treat FLT3-ITD AML

    Recruiting
    • Acute Myeloid Leukemia
    • FLT3-ITD Mutation
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Feb 3, 2020

      Acute Myeloid Leukemia With Gene Mutations Trial (Quizartinib DiHCl)

      No longer available
      • Acute Myeloid Leukemia With Gene Mutations
      • Quizartinib Dihydrochloride
      • (no location specified)
      Apr 14, 2020

      Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Baltimore (Bone Marrow Transplantation, Sorafenib, Sorafenib Tosylate)

      Completed
      • Acute Myeloid Leukemia With FLT3/ITD Mutation
      • Bone Marrow Transplantation
      • +2 more
      • Baltimore, Maryland
      • +1 more
      May 27, 2021